V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20079953 | 20133937 | 1.8 | null | Palliative (P) | 2016-05-11 | 2016-06-20 | Liposomal Doxorubicin (Caelyx) | 02 | N | DOCETAXEL + TRASTUZUMAB | 100988503 |
| 20080353 | 20133938 | 0.93 | 50 | Palliative (P) | 2017-03-20 | 2020-02-13 | IRINOTECAN + MDG + PANITUMUMAB | 2 | null | GEMCITABINE + OXALIPLATIN | 100887597 |
| 20080378 | 20133939 | 1.58 | 57.7 | Palliative (P) | 2021-09-09 | 2021-10-18 | MITOMYCIN | 02 | Y | CAP + RT | 101406107 |
| 20081090 | 20133940 | 1.75 | 54.7 | null | 2017-09-02 | 2017-09-19 | TEMOZOLOMIDE | 02 | null | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 100837512 |
| 20082020 | 20133941 | 1.65 | 64.9 | Palliative (P) | 2019-06-12 | 2019-11-16 | Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE | 100971003 |
| 20082507 | 20133943 | 1.56 | 62.8 | null | null | 2020-02-15 | null | 02 | null | DOXORUBICIN | 100645932 |
| 20082569 | 20133944 | 1.61 | 72 | 03 | 2019-06-23 | 2019-06-23 | FOCUS4 TRIAL | 01 | null | TEYSUNO | 100547969 |
| 20082837 | 20133945 | 1.5 | 99.9 | Palliative (P) | 2021-02-08 | 2021-02-08 | null | 02 | N | ECARBOX | 100594765 |
| 20083529 | 20133947 | null | null | Curative (C) | 2016-10-06 | 2017-10-05 | Doxorubicin 20mg/m2 7 day | null | null | ALECTINIB | 101510372 |
| 20083770 | 20133948 | 1.71 | 65 | Neo-adjuvant (N) | null | 2021-12-20 | Gemcitabine + Paclitaxel | null | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101147670 |
| 20083976 | 20133949 | 1.77 | 61.4 | Curative (C) | 2017-08-23 | 2017-09-01 | Cisplatin + Radiotherapy | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100604096 |
| 20084150 | 20133950 | 1.5 | 53.9 | Curative (C) | 2017-03-24 | 2017-03-31 | DARATUMUMAB | 01 | N | MPV | 100861511 |
| 20084733 | 20133954 | 1.65 | 66.4 | null | 2021-10-01 | 2021-10-15 | null | 02 | null | PHITT D SIOPEL-4 (A1, A2, A3) | 100461725 |
| 20084757 | 20133955 | 1.51 | 40.5 | Palliative (P) | 2018-09-23 | 2018-10-17 | TOPOTECAN | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100877133 |
| 20085158 | 20133957 | 1.65 | 47.6 | null | 2019-12-21 | 2020-01-05 | ETOPOSIDE | 01 | null | BORTEZOMIB + PANOBINOSTAT | 100071145 |
| 20085579 | 20133959 | 1.65 | 113.7 | 03 | 2016-03-19 | 2016-03-30 | BEAM | 02 | null | BORTEZOMIB | 100299022 |
| 20086610 | 20133960 | 1.83 | 62.8 | Palliative (P) | 2019-06-06 | 2019-06-06 | COSMIC TRIAL | 02 | N | CETUXIMAB + IRINOTECAN | 100997584 |
| 20086794 | 20133962 | 1.65 | 51.7 | Palliative (P) | 2019-12-29 | 2020-01-03 | Docetaxel + nintedanib | 02 | null | EOF | 100342773 |
| 20086997 | 20133963 | 0 | null | null | 2017-04-17 | 2017-06-01 | Fluorouracil + Streptozocin | 02 | N | CAPECITABINE + LOMUSTINE | 101736938 |
| 20088412 | 20133964 | 1.83 | 64.1 | Neo-adjuvant (N) | 2019-03-25 | 2019-06-30 | HEP SIOPEL 6 Cisplatin | 02 | null | RUXOLITINIB | 101157438 |
| 20088637 | 20133965 | 1.6 | 74.8 | Neo-adjuvant (N) | 2020-06-18 | 2020-06-23 | Pertuzumab + Trastuzumab IV | 02 | null | GEMCITABINE + OXALIPLATIN | 100286342 |
| 20090230 | 20133966 | 1.72 | 100.6 | Palliative (P) | 2018-12-02 | 2019-02-02 | Cisplatin +FU +Trastuzumab - Load | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100597289 |
| 20090331 | 20133967 | 1.75 | 54.6 | Curative (C) | 2018-01-16 | 2018-03-10 | Rituximab (Maintenance) | 01 | N | DARATUMUMAB | 101204687 |
| 20091353 | 20133968 | 1.73 | 65.3 | Palliative (P) | 2021-11-28 | 2021-12-26 | IPILIMUMAB + NIVOLUMAB | 02 | N | BEVACIZUMAB + CAPE + OXALIPLATIN | 101772499 |
| 20091883 | 20133970 | 1.57 | 83.3 | Curative (C) | 2020-01-15 | 2020-01-27 | PERTUZUMAB + TRASTUZUMAB | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101495733 |
| 20092200 | 20133972 | 1.75 | 89 | null | 2019-01-27 | 2019-02-24 | Capecitabine + Carboplatin + RT | 02 | null | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 100191475 |
| 20092250 | 20133973 | 1.87 | 98.15 | Palliative (P) | 2019-07-13 | 2020-01-24 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | PAZOPANIB | 101555793 |
| 20092372 | 20133974 | 1.65 | 61.5 | null | 2021-03-29 | 2021-07-14 | EOF | 02 | N | MITOMYCIN | 101615191 |
| 20092471 | 20133975 | 1.61 | 63 | null | 2020-10-28 | 2020-11-08 | ECarboX | 02 | Y | CAPECITABINE + STREPTOZOCIN | 100716384 |
| 20092505 | 20133976 | 1.51 | 89 | Palliative (P) | 2016-01-13 | 2016-03-14 | CEMIPLIMAB | 02 | null | CISPLATIN + RALTITREXED + TRASTUZUMAB | 100962493 |
| 20092564 | 20133977 | 1.81 | 76.6 | null | 2021-09-18 | 2021-09-26 | BCG Intravesical | 02 | null | PHITT D SIOPEL-4 (A1, A2, A3) | 100064765 |
| 20092602 | 20133978 | 1.72 | 39.9 | null | 2015-01-18 | 2015-01-19 | TEMOZOLOMIDE | 02 | N | EW EUROEWING 2012 ARM B VDC | 100565040 |
| 20093851 | 20133981 | 1.65 | 74.1 | null | 2018-01-30 | 2018-04-23 | Bortezomib (weekly) | 02 | null | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100023025 |
| 20094404 | 20133982 | 1.82 | 115.4 | null | 2016-05-17 | 2016-05-24 | Atezolizumab | 02 | null | ECF | 101436212 |
| 20095247 | 20133983 | 1.8 | 69.05 | Neo-adjuvant (N) | 2017-05-25 | 2017-07-06 | BCG Intravesical | null | Y | BEVACIZUMAB + FLUOROURACIL + OXALIPLATIN | 100658896 |
| 20095573 | 20133985 | 1.65 | null | Curative (C) | 2016-05-16 | 2016-08-13 | CISPLATIN + RALTITREXED + Trastuzumab | 02 | Y | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 101080666 |
| 20095656 | 20133986 | 1.8 | 88.2 | null | 2021-09-06 | 2021-09-08 | DOXORUBICIN | 02 | N | CAPECITABINE + DOCETAXEL | 100480046 |
| 20096764 | 20133987 | 1.69 | null | null | null | 2016-09-07 | Cabazitaxel | null | null | PALBOCICLIB | 100025524 |
| 20097335 | 20133988 | 1.54 | 70 | Palliative (P) | 2018-05-07 | 2018-05-17 | EOF | N | null | CAPECITABINE + STREPTOZOCIN | 100516175 |
| 20097826 | 20133990 | 1.87 | 80 | Palliative (P) | 2021-05-08 | 2021-05-08 | FOXFIRE TRIAL | 02 | N | TRIPLE INTRATHECAL | 100024902 |
| 20098699 | 20133991 | 1.71 | 14.8 | Curative (C) | 2016-07-28 | 2019-10-16 | FOXTROT TRIAL | null | N | ATEZOLIZUMAB | 101156006 |
| 20098972 | 20133992 | null | null | 03 | 2018-12-27 | 2019-03-28 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | Y | PAZOPANIB | 100251449 |
| 20099293 | 20133993 | 1.75 | 83.8 | Palliative (P) | 2020-01-16 | 2020-01-21 | SCOPE 2 TRIAL | 02 | N | PHITT | 101037736 |
| 20102118 | 20133996 | 1.8 | 80 | Curative (C) | 2022-04-29 | 2022-04-29 | Carboplatin + Pemetrexed | 02 | Y | ACTICCA-1 TRIAL | 101492115 |
| 20102709 | 20133997 | null | 95 | Palliative (P) | 2018-11-03 | 2018-11-03 | Epirubicin | N | null | ECARBOX | 100699180 |
| 20102753 | 20133998 | 1.59 | 68.2 | Palliative (P) | 2021-08-26 | 2021-11-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | NAB-PACLITAXEL | 101169511 |
| 20103311 | 20133999 | 1.46 | 46.7 | Palliative (P) | 2017-12-11 | 2017-12-11 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | CISPLATIN + RT | 100700222 |
| 20103600 | 20134001 | null | null | Curative (C) | 2019-08-15 | 2019-08-29 | Atezolizumab | 02 | Y | ECF | 100055026 |
| 20103732 | 20134002 | 1.56 | 21.7 | null | 2021-09-08 | 2022-01-13 | CAPE + OXALIPLATIN + TRASTUZUMAB | 1 | null | CARBO + FLUOROURACIL | 100835780 |
| 20104579 | 20134003 | 1.77 | 63.2 | null | 2018-01-24 | 2018-02-01 | Eribulin | 02 | null | IRINOTECAN + RALTITREXED | 101197827 |